eedq has been researched along with dihydroalprenolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilc, A; Vetulani, J | 1 |
| Enna, SJ; Nomura, S; Pilc, A; Vetulani, J | 1 |
2 other study(ies) available for eedq and dihydroalprenolol
| Article | Year |
|---|---|
Pretreatment with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline accelerates the electroshock-induced decrease in density of beta-adrenoceptors but not functional downregulation.
Topics: Adrenergic alpha-Antagonists; Animals; Catecholamines; Cerebral Cortex; Cyclic AMP; Dihydroalprenolol; Down-Regulation; Electroshock; Isoproterenol; Male; Quinolines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1990 |
An in vivo procedure for the selective inactivation of rat brain cerebral cortical alpha-adrenoceptors using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Topics: Adrenergic alpha-Antagonists; Animals; Cell Membrane; Cerebral Cortex; Clonidine; Cyclic AMP; Dihydroalprenolol; Inositol Phosphates; Isoproterenol; Male; Norepinephrine; Prazosin; Quinolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Yohimbine | 1989 |